Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 2018, 1535194

The Biology and Role of Interleukin-32 in Tuberculosis


The Biology and Role of Interleukin-32 in Tuberculosis

Wu Li et al. J Immunol Res.


Tuberculosis, caused by Mycobacterium tuberculosis, remains a leading cause of morbidity and mortality globally, with nearly 10.4 million new cases of incidence and over 1.7 million deaths annually. Drug-resistant M. tuberculosis strains, especially multidrug-resistant or extensively drug-resistant strains, have further intensified the problem associated with tuberculosis control. Host-directed therapy is a promising alternative for tuberculosis control. IL-32 is increasingly recognized as an important host molecule against tuberculosis. In this review, we highlight the proinflammatory properties of IL-32 and the mode of action of IL-32 in mycobacterial infections to inspire the development of novel immunity-based countermeasures and host-directed therapies against tuberculosis.


Figure 1
Figure 1
Endogenous IL-32-induced signaling pathway activation in macrophages and the potential roles of this pathway in M. tuberculosis infection.

Similar articles

  • [Frontier of Mycobacterium Research--Host vs. Mycobacterium]
    M Okada et al. Kekkaku 80 (9), 613-29. PMID 16245793.
    During the past decade, we have observed advance in tuberculosis research including novel vaccines, innate immunity (TLR), SNIP analysis and molecular mechanism of drug r …
  • [Development of Antituberculous Drugs: Current Status and Future Prospects]
    H Tomioka et al. Kekkaku 81 (12), 753-74. PMID 17240921. - Review
    Worldwide, tuberculosis (TB) remains the most frequent and important infectious disease causing morbidity and death. One-third of the world's population is infected with …
  • Interleukin-10 Family and Tuberculosis: An Old Story Renewed
    AE Abdalla et al. Int J Biol Sci 12 (6), 710-7. PMID 27194948. - Review
    The interleukin-10 (IL-10) family of cytokines consists of six immune mediators, namely IL-10, IL-19, IL-20, IL-22, IL-24 and IL-26. IL-10, IL-22, IL-24 and IL-26 are cri …
  • [Recent Progress in Mycobacteriology]
    M Okada et al. Kekkaku 82 (10), 783-99. PMID 18018602.
    Mycobacterium tuberculosis is one of the most successful bacterial parasites of humans, infecting over one-third of the population of the world as latent infection withou …
  • Inflammation and Tuberculosis: Host-Directed Therapies
    A Zumla et al. J Intern Med 277 (4), 373-87. PMID 24717092. - Review
    Tuberculosis (TB) is an airborne infectious disease that kills almost two million individuals every year. Multidrug-resistant (MDR) TB is caused by strains of Mycobacteri …
See all similar articles

Cited by 1 PubMed Central articles


    1. Matteelli A., Migliori G. B., Cirillo D., Centis R., Girard E., Raviglione M. Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control. Expert Review of Anti-Infective Therapy. 2007;5(5):857–871. doi: 10.1586/14787210.5.5.857. - DOI - PubMed
    1. Dahl C. A., Schall R. P., He H. L., Cairns J. S. Identification of a novel gene expressed in activated natural killer cells and T cells. Journal of Immunology. 1992;148(2):597–603. - PubMed
    1. Kim S. H., Han S. Y., Azam T., Yoon D. Y., Dinarello C. A. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity. 2005;22(1):131–142. doi: 10.1016/j.immuni.2004.12.003. - DOI - PubMed
    1. Kobayashi H., Huang J., Ye F., Shyr Y., Blackwell T. S., Lin P. C. Interleukin-32beta propagates vascular inflammation and exacerbates sepsis in a mouse model. PLoS One. 2010;5(3, article e9458) doi: 10.1371/journal.pone.0009458. - DOI - PMC - PubMed
    1. Chen Q., Carroll H. P., Gadina M. The newest interleukins: recent additions to the ever-growing cytokine family. Vitamins and Hormones. 2006;74:207–228. doi: 10.1016/S0083-6729(06)74008-0. - DOI - PubMed